Wells Fargo & Company »

Belite Bio shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-12-31 $16k 100 159.96

More positions owned by Wells Fargo & Company

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf Put Option (IVV)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom Put Option (AVGO)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon Call Option (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Meta Platforms Cl A Put Option (META)

View all positions for Wells Fargo & Company

Top funds holding Belite Bio

Darwin Global Management
RA Capital Management
Rtw Investments
Eventide Asset Management
Point72 Asset Management
Deerfield Management Company
Marshall Wace
UBS Group
MPM Oncology Impact Management
Holocene Advisors
Western Standard
Perceptive Advisors
Goldman Sachs Group
Soleus Capital Management
ADAR1 Capital Management

View all funds holding Belite Bio